UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | G | K | L | M | O | P | R | S | T | W
Number of items: 22.


Ah-See, M-L.W.; (2007) Evaluation of the vascular response to neoadjuvant chemotherapy in primary breast cancer. Doctoral thesis, University of London. Green open access


Birney, E; Stamatoyannopoulos, JA; Dutta, A; Guigo, R; Gingeras, TR; Margulies, EH; Weng, ZP; (2007) Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. NATURE , 447 (7146) 799 - 816. 10.1038/nature05874.

Boone, J.J.M.; (2007) The role of ErbB2 and BRCA1 in repair of drug-induced DNA damage. Doctoral thesis, University of London. Green open access


Chowdhury, T.; (2007) Investigation of the role of MLL-ENL in leukaemogenesis. Doctoral thesis, University of London. Green open access


Dancey, G; Violet, J; Othman, S; Parker, S; Green, A; Sharma, S; Francis, R; (2007) Phase I trial of the I-131-labelled Anti-CD25 antibody basiliximab in the treatment of patients with relapsed or refractory lymphoma. In: BLOOD. (pp. 199A - 200A). AMER SOC HEMATOLOGY


Geering, B; Cutillas, PR; Nock, G; Gharbi, SI; Vanhaesebroeck, B; (2007) Class IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , 104 (19) pp. 7809-7814. 10.1073/pnas.0700373104.

Geering, B; Cutillas, PR; Vanhaesebroeck, B; (2007) Regulation of class IA PI3Ks: is there a role for monomeric PI3K subunits? In: (Proceedings) 3rd Focused Meeting on PI3K Signalling and Disease. (pp. pp. 199-203). PORTLAND PRESS LTD


Kiakos, K; Sato, A; Asao, T; McHugh, PJ; Lee, M; Hartley, JA; (2007) DNA sequence-selective adenine alkylation, mechanism of adduct repair, and in vivo antitumor activity of the novel achiral seco-amino-cyclopropylbenz[e]indolone analogue of duocarmycin AS-I-145. MOL CANCER THER , 6 (10) 2708 - 2718. 10.1158/1535-7163.MCT-07-0294.

Kiakos, K.; (2007) Molecular and cellular pharmacology of novel chiral and achiral CC-1065/duocarmycin analogues. Doctoral thesis, University of London. Green open access

Koch, CM; Andrews, RM; Flicek, P; Dillon, SC; Karaoz, U; Clelland, GK; Wilcox, S; (2007) The landscape of histone modifications across 1% of the human genome in five human cell lines. GENOME RES , 17 (6) 691 - 707. 10.1101/gr.5704207.

Kulkarni, AA; Loddo, M; Leo, E; Rashid, M; Eward, KL; Fanshawe, TR; Butcher, J; (2007) DNA replication licensing factors and aurora kinases are linked to aneuploidy and clinical outcome in epithelial ovarian carcinoma. CLIN CANCER RES , 13 (20) 6153 - 6161. 10.1158/1078-0432.CCR-07-0671.


Lewis, IJ; Nooij, MA; Whelan, J; Sydes, MR; Grimer, R; Hogendoorn, PCW; Memon, MA; (2007) Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: A randomized phase III trial of the European Osteosarcoma Intergroup. J NATL CANCER I , 99 (2) 112 - 128. 10.1093/inci/djk015.


Maloney, A; Clarke, PA; Naaby-Hansen, S; Stein, R; Koopman, J-O; Akpan, A; Yang, A; (2007) Gene and protein expression profiling of human ovarian cancer cells treated with the heat shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin. CANCER RESEARCH , 67 (7) pp. 3239-3253. 10.1158/0008-5472.CAN-06-2968.


Okkenhaug, K; Ali, K; Vanhaesebroeck, B; (2007) Antigen receptor signalling: a distinctive role for the p110 delta isoform of Pl3K. TRENDS IN IMMUNOLOGY , 28 (2) 80 - 87. 10.1016/j.it.12.007.

Okkenhaug, K; Ali, K; Vanhaesebroeck, B; (2007) Antigen receptor signalling: a distinctive role for the p110delta isoform of PI3K. Trends in Immunology , 28 (2) 80 - 87. 10.1016/j.it.2006.12.007. Green open access


Penn, H; Howie, AJ; Kingdon, EJ; Bunn, CC; Stratton, RJ; Black, CM; Burns, A; (2007) Scleroderma renal crisis: patient characteristics and long-term outcomes. QJM-INT J MED , 100 (8) 485 - 494. 10.1093/qjmed/hcm052.

Plummer, R; Attard, G; Pacey, S; Li, L; Razak, A; Perrett, R; Barrett, M; (2007) Phase 1 and pharmacokinetic study of lexatumumab in patients with advanced cancers. CLIN CANCER RES , 13 (20) 6187 - 6194. 10.1158/1078-0432.CCR-07-0950.


Rachid, Z; Brahimi, F; Qiu, Q; Williams, C; Hartley, JM; Hartley, JA; Jean-Claude, BJ; (2007) Novel nitrogen mustard-armed combi-molecules for the selective targeting of epidermal growth factor receptor overexperessing solid tumors: Discovery of an unusual structure-activity relationship. J MED CHEM , 50 (11) 2605 - 2608. 10.1021/jm070144p.


Sullivan, A; Lu, X; (2007) ASPP: a new family of oncogenes and tumour suppressor genes. BRITISH JOURNAL OF CANCER , 96 (2) pp. 196-200. 10.1038/sj.bjc.6603525.

Swanton, C; Marani, M; Pardo, O; Warne, PH; Kelly, G; Sahai, E; Elustondo, F; (2007) Regulators of mitotic arrest and ceramide metabolism are determinants of sensitivity to paclitaxel and other chemotherapeutic drugs. CANCER CELL , 11 (6) pp. 498-512. 10.1016/j.ccr.2007.04.011.


Toumpanakis, C; Meyer, T; Caplin, ME; (2007) Cytotoxic treatment including embolization/chemoembolization for neuroendocrine tumours. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM , 21 (1) pp. 131-144. 10.1016/j.beem.2007.01.005.


Wood, KA; Hoskin, PJ; Saunders, MI; (2007) Positron emission tomography in oncology: A review. CLIN ONCOL-UK , 19 (4) 237 - 255. 10.1016/j.clon.2007.02.001.

This list was generated on Sun Oct 23 03:29:34 2016 BST.